CD4 and glioblastoma: Furthermore, in-depth phenotyping of PB immune cells also revealed changes in the effector and memory Tc compartment with similarities in KLRG1+ CD4+ TTE between RRMS and glioblastoma patients and differences in CD8+ effector and memory Tc and activated CD4+ TSCM.